PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia [Financial Post (Toronto, Ontario, Canada)]
![Financial Post](../../../Content/images/providers/Financial Post.png)
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Financial Post
ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSA SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) — In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. Held in Houston, the event brought together scientific and medical experts focused on sleep health. From exploration into the prevalence of insomnia in the Americas to the reduction in emergency room visits among COMISA patients on PAP therapy – the ResMed-supported research demonstrated the effectiveness and value of positive airway pressure (PAP) treatment for OSA. Article content “The real-world evidence used in our clinical research continues to demonstrate the effectiveness of PAP therapy fo
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- Emerging Respiratory Care Companies, 2024: Strategic Profiles and Growth Opportunities to 2028 [Yahoo! Finance]Yahoo! Finance
- ResMed Inc. (NYSE: RMD) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.MarketBeat
- S&P 500 Gains and Losses Today: Oil Stocks Surge Amid Global Tensions, Summer Demand [Yahoo! Finance]Yahoo! Finance
- Inspire Medical, ResMed decline following Lilly tirzepatide sleep apnea data [Seeking Alpha]Seeking Alpha
- Top Stock Movers Now: Affirm, Nvidia, ResMed, and More [Yahoo! Finance]Yahoo! Finance
RMD
Earnings
- 4/25/24 - Beat
RMD
Sec Filings
- 6/11/24 - Form 4
- 6/10/24 - Form 4
- 6/10/24 - Form 4
- RMD's page on the SEC website